WHO ICTRP trial
Effect of pentoxifylline on inflammatory factors and quality of life in…
IRCT20170609034406N3 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20170609034406N3 |
|---|---|
| Public title | Effect of pentoxifylline on inflammatory factors and quality of life in hemodialysis patients |
| Scientific title | Effect of pentoxifylline on inflammatory factors and quality of life in hemodialysis patients |
| Primary sponsor | Tabriz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | End Stage Renal Disease. Chronic kidney disease, stage 5;N18.5 |
| Interventions | Intervention 1: Intervention group: The treatment group consists of 50 patients receiving 400 mg orally of Pentoxifylline daily for 3 months. Intervention 2: Control group consisted of 50 patients receiving 400 mg orally of placebo(which… |
| Registration date | Sep 21, 2019 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: